We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of L-Theanine in Boys With ADHD

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00291070
First Posted: February 13, 2006
Last Update Posted: May 6, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of British Columbia
February 9, 2006
February 13, 2006
May 6, 2008
October 2005
July 2006   (Final data collection date for primary outcome measure)
Cognitive performance
Same as current
Complete list of historical versions of study NCT00291070 on ClinicalTrials.gov Archive Site
Sleep quality, hyperactive behaviors, anxiety
Same as current
Not Provided
Not Provided
 
Effects of L-Theanine in Boys With ADHD
A Double Blind, Randomized Placebo Controlled Clinical Trial Examining the Effects of L-Theanine (Suntheanine®) in Male Child Subjects With Attention Deficit Hyperactivity Disorder
This study will examine the effects of L-theanine (an amino acid found in green tea) on the behavior, cognitive performance and sleep quality of boys with ADHD.
Not Provided
Interventional
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Attention Deficit Hyperactivity Disorder
Drug: L-theanine
This study will examine the effects of L-theanine (an amino acid found in green tea) on the behavior, cognitive performance and sleep quality of boys with ADHD.
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
100
July 2006
July 2006   (Final data collection date for primary outcome measure)

Inclusion Criteria:

Diagnosis of attention deficit hyperactivity disorder (ADHD)

Exclusion Criteria:

Sexes Eligible for Study: Male
8 Years to 12 Years   (Child)
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
 
NCT00291070
C04-0605
Not Provided
Not Provided
Not Provided
Dr. Michael Lyon, University of British Columbia
University of British Columbia
Not Provided
Principal Investigator: Dr. Michael Lyon University of British Columbia
University of British Columbia
April 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP